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Abstract: The coupling reactions of polyethylene glycol (PEG) with two different nano-carbonaceous
materials, graphene oxide (GO) and expanded graphene oxide (EGO), were achieved by amide bond
formations. These reactions yielded PEGylated graphene oxides, GO-PEG and EGO-PEG. Whilst
presence of the newly formed amide links (NH-CO) were confirmed by FTIR stretches observed
at 1732 cm−1 and 1712 cm−1, the associated Raman D- and G-bands resonated at 1311/1318 cm−1
and 1584/1595 cm−1 had shown the carbonaceous structures in both PEGylated products remain
unchanged. Whilst SEM images revealed the nano-sheet structures in all the GO derivatives (GO/EGO
and GO-PEG/EGO-PEG), TEM images clearly showed the nano-structures of both GO-PEG and
EGO-PEG had undergone significant morphological changes from their starting materials after the
PEGylated processes. The successful PEGylations were also indicated by the change of pH values
measured in the starting GO/EGO (pH 2.6–3.3) and the PEGylated GO-PEG/EGO-PEG (pH 6.6–6.9)
products. Initial antifungal activities of selective metallic nanomaterials (ZnO and Cu) and the four
GO derivatives were screened against Candida albicans using the in vitro cut-well method. Whilst
the haemocytometer count indicated GO-PEG and copper nanoparticles (CuNPs) exhibited the best
antifungal effects, the corresponding SEM images showed C. albicans had, respectively, undergone
extensive shrinkage and porosity deformations. Synergistic antifungal effects all GO derivatives
in various ratio of CuNPs combinations were determined by assessing C. albicans viabilities using
broth dilution assays. The best synergistic effects were observed when a 30:70 ratio of GO/GO-PEG
combined with CuNPs, where MIC50 185–225 µm/mL were recorded. Moreover, the decreased
antifungal activities observed in EGO and EGO-PEG may be explained by their poor colloidal stability
with increasing nanoparticle concentrations.
Keywords: antimicrobial nanoparticles; PEGylated graphene oxide; Candida albicans; copper
nanoparticles (CuNPs); antifungal; minimum inhibitory concentration (MIC)
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1. Introduction
Research in nanomaterials is rapidly growing, especially due to their potential for biomedical
and healthcare applications. Graphene-based nanomaterials, such as carbon nanotubes and fullerenes,
have created new avenues for researchers in nanomedicine, sensors, catalysis, etc. [1–3]. Their proven
biocompatibility and low cytotoxicity have also attracted tremendous attention from biomedical
scientists and pharmaceutical industries [4]. The most promising biological application involves
using graphene as a delivery system for drugs; reports have shown that functionalised graphene can
effectively shuttle small biological molecules into cells via the endocytic pathway, which is subsequently
released at the target sites [5]. Moreover, their ability to form a vast number of functionalised graphene
vehicles and to anticipate hydrophobic interactions in the central nervous system (CNS) have broadened
the research interests in graphene chemistry and their potential in bio-medical engineering [6,7].
Graphene oxide (GO) is one of the functionalised graphitic derivatives, which has a well-known
two-dimensional layer-structure that can be obtained by oxidative exfoliation of graphite [8]. Each
fundamental layer of GO comprises of a sp2 hybridised carbonaceous skeleton forming a highly
conjugated hexagonal structure, and each layer is held strongly by intermolecular covalent bonds [9].
Typically GO contains quaternary carbonyl groups, and it is also embedded with active epoxy- and
carboxyl- groups that are situated at the structures exterior [10]. The presence of these functional groups
facilitate surface modification via solution processing, including carboxylation and reduction. Due
to the flexibility for surface functionalization of GO, the modified graphene oxides are ideal systems
for studying the correlations between phase change behaviour and their surface properties. On the
other hand, expanded graphene oxide (EGO) has a slightly different carbonaceous structure. EGO
can be obtained by the reductions of graphite oxide [11] and is a promising precursor for high-quality
products with enhanced properties due to its larger molecular surface area.
There have been numerous studies demonstrating antimicrobial properties of GO against a range
of harmful pathogens, including both Gram-positive and -negative bacteria and biofilm forming
microorganisms [12,13]. This antimicrobial effect is thought to be facilitated through both chemical
and physical interactions of the graphene sheets with the bacterial cell membrane, which leads to
morphological alterations within the cell [14]. It has been theorised that the sharp edges which form
the flat atomic structure of graphene enable it to pierce through the cell membrane, thereby physically
disrupting its integrity.
Conjugations of polyethylene glycol (PEG) with polymers is known to effectively improve
biocompatibility [15]. Similarly, surface modifications of graphene using PEG (a process known as
PEGylation), has also been widely investigated and promoted as a carrier to deliver hydrophobic
anticancer drugs in mammalian systems [16]. PEG is a very useful biological reagent because of its
minimal cytotoxicity, high biocompatibility and protein-resistant nature. It also has good solubility in
water and is miscible in most common organic solvents for chemical synthesis [17–20]. PEG in the
PEGylated GO has also been used as an inhibitor of bacterial wall synthesis [21,22], and antimicrobial
synergistic effects have been reported when these PEGylated GO systems were combined with silver
nanoparticles [23–27].
Candidiasis is one of the most frequent fungal infections in hospitals today [28], caused largely by
the number of immunocompromised patients who are at a greater risk of developing this systemic fungal
infection [29–31]. Of the Candida species responsible, Candida albicans (C. albicans) remains the most
prevalent. One important factor that contributes to the pathogenesis of C. albicans is biofilm formation,
as these fungal cells can form biofilms on biological and inert surfaces. Catheter-related infections are
often caused by the C. albicans’ ability to form biofilms, which can often be fatal, exacerbated by the
growing resistance against most currently available antifungals agents [29,32]. Once the biofilm has
formed, the sessile cells contained inside the biofilm have been proven to withstand some of the most
effective drugs that are used to treat other yeast infections [33,34]. These are some of the major factors
which attribute towards high mortality rates in patients with aggressive forms of candidiasis among
various other clinical failures [35]. Due to the growing antifungal resistance of C. albicans along with
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the existing global concern of antimicrobial resistance (AMR) from other deadly pathogenic bacteria,
research into alternative sources to combat AMR is becoming increasingly important.
In this study, we first report the synthesis of two different PEGylated graphene oxides (GO-PEG
and EGO-PEG) that were prepared via amide bond formations as shown in Figure 1. In order to
understand the structure activity relationship between these nano-graphene oxides and microorganisms,
the physical and chemical characteristics of these PEGylated products were investigated using FTIR
and Raman spectroscopy, and scanning and transmission electron microscopies (SEM and TEM).
Furthermore, the physiochemical behaviour of these GO and PEGylated GO derivatives were studied
by measuring their surface charges (and pH), hydrodynamic sizes and particle distributions using
dynamic light scattering (DLS) techniques. Considering nano-silver has becoming a more common
antimicrobial reagent and that microorganisms may become resistant to nano-silver in the near future,
therefore, we chose to use copper nanoparticles (CuNPs) in our study and to investigate the potential
synergistic antifungal activities in the presence of different graphene oxides. Antifungal activities
of a total of five individual standard nanomaterials, including two graphene oxide standards (GO
and EGO), their PEGylated derivatives (GO-PEG and EGO-PEG) and copper nanoparticles (CuNPs)
were initially evaluated using an agar plate ‘cut-well’ method. The antifungal susceptibilities and
synergistic effects were finally quantified by the minimum inhibitory concentrations (MIC) of each
GO/CuNPs and GO-PEG/CuNPs nanocomposites using broth microdilution methods.
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2. Materials and Methods
2.1. Nanomaterials
As shown in Figure 1, two different graphene oxides nano-sheets (GO and EGO) were employed
and used as precursors of GO-PEG and EGO-PEG. Graphene oxide (GO) with a specific surface
Nanomaterials 2020, 10, 819 4 of 19
area of 20–35 m2/g and median mesoporous pore diameter of 127.5 Å was provided by NanoInnova
Technologies SL. (Madrid, Spain). Expanded graphene oxide (EGO) with a specific surface area
of 116 m2/g and median mesoporous pore diameter of 220 Å was provided by Castilla-La Mancha
University (Madrid, Spain). EGO was prepared using a pilot method reported by Lee et al. [11].
Elemental copper nanoparticles (CuNPs) were spherical with a particle sizes ranging from 10–40 nm
and was manufactured by CF Nanotechnology® (Suzhou, China).
2.2. Synthesis of PEGylated Graphene Oxides (GO-PEG and EGO-PEG)
For the PEGylation of GO and EGO (Figure 1), 4arm-PEG5K-NH2 was used as the PEG coupling
reagent, while 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hypochlorite (EDC HCl) was employed
as the carboxyl activating regent to enable amide bond formation during the chemical conjugation.
Both chemicals were purchased from Sigma-Aldrich (Madrid, Spain). All materials were used as
received unless otherwise indicated. The GO-PEG and EGO-PEG were synthesised by modification of
the method reported by Zhu et al. [21].
A mixture of graphene oxide nanoparticles (100 mg) and 4arm-PEG-NH2 (300 mg) were suspended
in deionized water (100 mL) which was bath-sonicated for 5 min. EDC HCl (30 mg) was then added and
the mixture was bath-sonicated for a further 40 min at room temperature, this was followed by further
addition of EDC HCl (80 mg) and the mixture was stirred overnight. The resulting crude reaction
mixtures were subjected to centrifugation (Digicen 21 centrifuge, Orto Alresa Spain) at 5000 rpm
to remove any unreacted PEG. The supernatant was then removed and the solid was washed and
subsequently filtered under vacuum. Finally, the PEGylated product was filtered to dryness under
reduced pressure and then air dried for 24 h at room temperature. The same experimental procedure
was employed to obtain EGO-PEG. Both GO-PEG and EGO-PEG were isolated as black solids.
2.3. Nanoparticle Dispersions for Physiochemical and Antifungal Testing
In this study, GO, EGO, GO-PEG, EGO-PEG and CuNPs dispersions with varying ratios were
prepared for physiochemical and antifungal evaluations. A 0.1% w/v stock suspension of each
nanoparticle dispersion was prepared by first suspending 20 mg of nanocomposites into 20 mL of pure
water (Acros, Organics-Fisher scientific UK), which was then radiated in a Vibra-cell 750 ultrasonic
liquid processor (Sonics and Materials®, Newtown, CT, USA) for 2–3 min at 50% working amplitude
with an applied pulse sequence (20 s on and 5 s off). All suspensions were cooled either in ice/water bath
immediately after each dispersion process. When required, different elemental ratios of nanocomposites
were prepared freshly using standard dilution method.
2.4. FT-IR Spectroscopy
Infrared spectra of GO, GO-PEG, EGO and EGO-PEG samples were measured in a FT-IR Nicolet
iS50 (Thermo Scientific, Spain) instrument, equipped with ATR germanium technique (Miracle™ Single
Reflection ATR, Pike, Spain). Powder samples were loaded directly onto the germanium crystal stage
and secured by a compressor rod. Blanks were performed prior to each sample submission; all spectra
were measured at a wavenumber range between 3500–500 cm−1.
2.5. Raman Spectroscopy
Raman spectra were obtained by a Renishaw inVia Raman microscope (Gloucestershire, UK)
equipped with a WiRE 3.4 software supplied by the manufacturer. All measurements were performed
at 785 nm excitation wavelength and a 2 mW power laser. All powder samples were presented on
a microscope slide with an approximate examined area of 20 × 20 µm2 and each measurement was
taken after an average of 20 scans. The data were further processed using the BioRed® (Philadelphia,
PA, USA) program and all visible Raman shifts were studied against the references supported by the
database within the program.
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2.6. SEM and TEMMicroscopy
The surface morphologies of GO, GO-PEG, EGO and EGO-PEG nanoparticles were studied using
scanning electron microscopy (SEM) and transmission electron microscopy (TEM). All the SEM images
for GO, EGO and their PEG-derivatives were acquired using an X-Max Oxford Instrument (Oxford,
UK) at an operating power range between 127 eV and 5.9 kV. One drop of diluted suspension of each
nanoparticle sample was placed on a silicon wafer, which was attached to an aluminium sample stub
with a conductive carbon adhesive. All the biological samples were fixed using 2.5% glutaraldehyde
and 2% osmium tetroxide, washed with phosphate butter and gradient mixtures of ethanol/water [36].
Yeast samples were then dehydrated with acetone and air dried for 24 h. All biological samples
were mounted on SEM stubs the same way as described before, and all SEM images of biological
samples were acquired using a JEOL JCM-5700 (Welwyn Garden City, UK) instrument. All SEM
samples were dried under vacuum and coated with 2–3 nm of gold using an Emitech SC7620 sputter
(Quorum Technologies, Ltd., East Sussex, UK) prior imaging acquisitions. All images were collected
and processed using in-built software within the instrument. TEM images of GO and EGO samples
were acquired using a JEOL 2100 instrument (Tokyo, Japan) operating at 200 kV. For this study, a few
drops of each dispersions containing a concentration of 0.005 mg/mL of solids were placed on a copper
grid and volatile solvents were evaporated prior to observation.
2.7. Colloidal Stability and pH Measurement of Nanoparticle Dispersions
Zeta-potentials of GO, GO-PEG, EGO and EGO-PEG aqueous dispersants at concentrations of
10, 50 and 100 ppm were measured using the micro-electrophoresis technique equipped with a laser
Doppler velocimetry (Zetasizer Nano ZS, Malvern, UK). All pH values were measured at seven
different concentrations (10, 25, 50, 100, 250, 500 and 1000 ppm) using an Accumet™ AP110 Portable
pH Meter (Fisherbrand™, Leicestershire, UK). The pH probe was calibrated using pH 7 and pH 4
buffer between analysis of different samples. All zeta potential and pH values of dispersants were
measured at 22.0 ± 0.1 ◦C. All values reported were determined from the mean values of at least three
successive measurements.
2.8. Nanoparticle Tracking Analysis at Real-Time
Nanoparticle tracking analyses were performed using a NanoSight LM14 (Malvern Instruments,
UK) equipped with a green laser source (532 nm) and a CMOS camera. Each nanoparticles dispersant
of 0.005% w/v (50 ppm), 0.01% w/v (100 ppm) and 0.025% w/v (250 ppm) was directly loaded into
sample chamber using a syringe, detection was measured under a static mode at room temperature.
Real-time visualisation of the nanoparticles was optimised by adjusting the NTA camera shutter, gain
and laser power. All nanoparticles in each sample were tracked and captured for 30 s in a single
analysis, which were acquired in three technical and software replicates. Hydrodynamic size ranges
and particle concentrations were obtained from means values of at least three successful replicates.
All data was collected using in-built software (NTA 3.2 Dev Builds 3.2.16) and was further processed
using MS Excel (Microsoft, Redmond, WA, USA).
2.9. Cultures and Biological Reagents
Candida albicans (ACTT 2091) was obtained from the University of Hertfordshire collection
(Life and Medical Sciences), Mueller-Hinton (MH) agar, Sabouraud Dextrose Agar (SDA), yeast peptone
dextrose agar (YPD) along with other agar/broth ingredients were purchased from Sigma-Aldrich,
UK. All the saline and buffer solution used in this study were freshly prepared from the bulk powder
(SIGMA-Aldrich, UK) according to manufacture guidance and were all sterilised in an autoclave
(121 ◦C, 15–20 min) prior to in vitro studies. Trypan Blue (Sigma-Aldrich, UK) was used to stain dead
cells while counting viable colonies using a haemocytometer. Other bio-reagents for performing MIC
assays, which included RPMI 1640 L-glutamine with sodium bicarbonate, Clotrimazole, PBS, XTT
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sodium salt and Menadione, were all purchased at Sigma-Aldrich (Dorset, UK). The materials were
stored at room temperature, except RPMI 1640 medium which was stored at −20 ◦C until used.
2.10. Susceptibility Tests of Standard Alone Nanomaterials against Candida Albicans
A modification of the ‘cut-well’ method [37] was used to screen antifungal activities of standard
nanomaterials (ZnO, Cu, GO, EGO, GO-PEG and EGO-PEG) against C. albicans (ATCC 2091) as the
model organism. C. albicans was aerobically cultivated in SDA for 48 h at 30 ◦C. Colonies were
taken with a sterile loop and suspended in 7 mL of sterile Ringer saline. The mixture was then
vortexed for 15 s and the cell population was adjusted to 1 × 106 to 1 × 108 colony-forming units
(cfu)/mL. The yeast suspension (150 µL) was inoculated on previously ‘well-cut’ YPD agar plates
using a sterile glass spreader. Negative controls (pure water) and three replicates of different standard
nanomaterials dispersants (18 µL) at a concentration of 0.1%w/v (1000 ppm) were pipetted into each
well (5 mm × 6 mm, diameter × depth) on the yeast inoculated agar plates, all treated yeast cultures
were then incubated at 30 ◦C for 48 h. After the incubation period, inhibitory effect could be observed
by the absence of visible colonies. To quantify colonies in each treated yeast well, fresh Ringer saline
(18 µL) was added into each well, which was then transferred into an Eppendorf and further diluted
with mixture of Ringer saline and Trypan blue (0.025%). Quantification of the treated and controlled
yeast cells were performed using a haemocytometer. A susceptibility test was repeated twice, a total of
six replicates of viable yeast-counts were obtained and the raw data was processed using MS Excel
(Microsoft, Redmond, WA, USA).
2.11. Determination of Minimum Inhibitory Concentrations (MIC) of Nanomaterial Composites
The in vitro synergistic antifungal study was performed using four different ratios of graphene
oxide derivatives (GO, EGO, GO-PEG and EGO-PEG) with CuNPs. The GO:Cu ratios were 96:4,
70:30, 30:70 and 1:99, respectively. MIC assays of a total of 16 combinations were achieved using a
modification method that was outlined by Pierce et al. [38].
C. albicans (ATCC 2091) was cultured overnight in YPD agar for 24 h at 30 ◦C. A colony of the
fresh C. albicans was suspended into 1 mL of phosphate-buffered saline (PBS) and the mixture was
centrifuged (Hettich centrifuge EBA200, Bäch, Switzerland) at 6000 RPM for 5 min. The resulting
C. albicans cells were washed again with PBS and then re-suspended in 1 mL of RPMI 1640 medium.
Cell forming unit (cfu/mL) of C. albicans was measured using a haemocytometer and the concentration
of the cells was re-adjusted to 1.0 × 106 cells/mL in RPMI 1640 medium. A total of 100 µL of the
C. albicans broth and 100 µL of the corresponding the Graphene Oxide and Copper nanoparticle ratio
(96:4, 70:30, 30:70 and 1:99) at different concentrations (0, 7, 15, 31, 62, 125, 250, 500 µg/mL) were then
added into a 96 multiwell plate, and the mixtures were then incubated at 30 ◦C for 24 h.
A saturated XTT reagent was prepared by dissolving 0.5 g of XTT powder into 1 L of PBS and this
solution was covered in foil during preparation. A10 mL working volume of the XTT reagent was
filtered using MilliPore syringe filters (0.22 µm-pore size) and stored at −70 ◦C before used. For the
Menadione reagent, a 10 mM stock solution in 100% acetone was prepared and stored at −70 ◦C
before used. After 24 h of incubating the C. albicans cells in nanoparticle suspensions, 100 µL of the
freshly prepared XTT/Menadione reagent (1 µL Menadione + 10 mL XTT) was added to each well
of the 96 multi-well plate. The plate was covered in foil and incubated for further two hours at
37 ◦C before O.D. values (λ 490 nm) was obtained from using a micro-plate colorimeter (CLARIOstar
BMG Labtech, Offenburg, Germany). All the viability values presented were obtained from average
values of replicates of two successful experiments. The MIC50 values represent the lowest antifungal
concentration leading to >50% reduction in colorimetric readings.
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3. Results and Discussion
3.1. Chemical and Morphological Characterization of GO, EGO, GO-PEG and EGO-PEG
Figure 2a–d shows the FTIR spectra obtained from the four different graphene oxide derivatives,
GO, GO-PEG, EGO, and EGO-PEG. The FTIR spectrum of GO (Figure 2a) shows two vibrational bands
at 1105 and 1732 cm−1, corresponding to the C–OH and C=O stretches from the carboxylic acid group
(–COOH) within the graphitic structure. Whereas the band resonated at 1622 cm−1 was attributed to
the bending mode in the sp2 hybridised C=C within the highly conjugated GO structure. The broad
signal observed between 3500–3000 cm−1 can be attributed to OH stretching due to intermolecular
hydrogen bond interactions between the carboxylic acid groups (COOH) presence on the outskirt of
the GO structure. Thus, the IR spectrum of GO is consistent with that reported by Marcano et al. [39].
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In contrast, a new band was found in the FTIR spectrum of GO-PEG (Figure 2b) at 2870 cm−1
and this corresponded to the stretching of the C–H bonds derived from PEG coupling. As expected,
an amide signal (NH–CO) was observed at 1732 cm−1 after the amidation coupling reaction during
PEGylation. Although resonated at the same wavelength with GO, however, the C=O signal in the
PEGylated product was much weaker [40].
Figure 2c,d show the FTIR spectra of EGO and EGO-PEG respectively. The very broad bands
at 3250–2250 cm−1 appeared in both EGO (Figure 2c) and EGO-PEG (Figure 2d) suggested that the
samples were hygroscopic. The increased hygroscopicity found in the resulting EGO-PEG made it
difficult to identify the N-H stretch, which was expected after the PEGylation process. Although the
FTIR spectra of EGO (Figure 2c) and EGO-PEG (Figure 2d) were not as resolved, the C=O stretches
observed in the corresponding acidic EGO were quite different to the PEGlyated product (1752 cm−1 vs.
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1712 cm−1). The band observed at 1712 cm−1 EGO-PEG (Figure 2d) was therefore associated with the
amide group (NH–CO) formed after the EGO had chemically coupled with PEG as shown in Figure 1.
In contrast, the band at 1752 cm−1 observed in the EGO sample, would be a characteristic carbonyl
(C=O) stretch associated to the carboxylic acid group in the starting material.
The above evidence suggested that the coupling reaction of PEG with the two types of graphene
oxides (GO and EGO) had successfully occurred and that new amide bonds were formed yielding
PEGylated graphene oxide (GO-PEG) and PEGylated expanded graphene oxide (EGO-PEG).
In addition to the FTIR study, the four different graphene oxide derivatives were also analysed
using complementary Raman spectroscopy. Figure 3a–d show the Raman spectra of GO, GO-PEG, EGO
and EGO-PEG, respectively. Two distinctive signals, the D and G bands were observed within the range
of 1300–1650 cm−1 in all four samples, which were attributed to the presence of sp3/sp2 hybridized
carbon-carbon bonds in the graphitic compounds. Unlike the pristine graphene, the strong and broad
D band and high I(D)/I(G) ratio in our GO samples indicated their lattice distortions and large amount
of sp3-like defects due to their oxidised nature [41]. This Raman feature is quite commonly found in
graphene oxide species.
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Figure 3. Ra an spectra of (a) , (b) -PE , (c) E and (d) E -PE .
Figure 3a shows the Raman spectrum of GO which shows peak D at 1323 cm−1 and peak G at
1590 cm−1, while in the EGO sample peak D appeared at 1328 cm−1 and peak G at 1598 cm−1, confirming
the distortions of the network (Figure 3a,c). In the case of the GO-PEG conjugated materials (Figure 3b)
and EGO-PEG (Figure 3d), the D and G bands were shifted to give lower wavenumbers at 1311 cm−1
and 1318 cm−1 for the D bands and 1584 cm−1 and 1595 cm−1 for G bands, respectively. In the case of
band D, the displacement was more pronounced. It was also observed that the signal to noise ratios
were much better resolved in the PEGylated samples when comparing to the starting GO/EGO, hence,
the addition of the organic moiety (i.e., the PEG groups) had enhanced light scattering intensities.
Figure 4a,b show the SEM images of GO and GO-PEG. As shown in Figure 4a, GO demonstrated
a sheet-liked structure with sharp edges and a smooth surface. Although the subsequent PEGylated
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product, GO-PEG appeared to be heavily agglomerated, a laminar nano-layer structure can still
be seen in the corresponding SEM image (Figure 4b). The observed agglomerations and a more
randomised structure in GO-PEG can be explained by the spatial interactions between the newly
formed PEG-arms, of which had grafted onto the edges of the GO layers [42]. Subsequently giving rise
to the thickness increase, similar effect has been reported by Lu et al. upon the functionalisation with
aminoethanesulfonic acid via amide bond formations [43].
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Figure 4c,d shows the TEM micrographs of GO and GO-PEG, as illustrations in dispersed and
singular forms. The TEM image of GO (Figure 4c) depicted very thin and transparent sheets, whereas
the corresponding PEGylated product, GO-PEG appeared to have deformed edges. Again, such
morphological changes were expected, due to the presence of additional PEG groups situated on the
surface of the GO layer, hence, the layer had become denser.
Figure 5a,b shows SEM micrographs obtained from EGO and EGO-PEG. As can be seen in
Figure 5a, these expanded graphene oxide (EGO) derivatives still appeared as a layered-structure, but
heavily agglomerated. The particle surface areas in EGO and EGO-PEG were found to be much smaller
than those were seen in the GO and GO-PEG nano-sheets (Figure 4a,b). This physical behaviour was
also observed in the corresponding TEM image.
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3.2. Physiochemical Characterisations of GO, GO-PEG, EGO and EGO-PEG
With an aim to understand how different graphene oxide derivatives may have interacted and
attributed to the observed antifungal effects against C. albicans, we investigated the physiochemical
behavior of each standard alone, i.e., GO, GO-PEG, EGO, and EGO-PEG, at different aqueous
concentrations. As shown in Figure 6a, the pH levels of each graphene oxide derivative were measured
at seven different dilutions (10, 25, 50, 100, 250, 500 and 1000 ppm). The pH observed clearly shows
that both starting GO and EGO were acidic, as their concentrations increased from 10 ppm to 1000 ppm,
the pH values of both GO and EGO dropped significantly to 3.3 (± 0.03) and 2.6 (± 0.02), respectively.
It is worth noting that the pH levels of both GO-PEG and EGO-PEG stabilised to near neutral pH level
(~pH 7) at all concentrations. This provided evidence that successful PEGylation had occurred during
the coupling syntheses. In order to determine the surface charges and to understand the colloidal
stabilities of the graphene oxide nanoparticle derivatives, zeta potentials of GO, GO-PEG, EGO and
EGO-PEG dispersants were measured at concentrations 10, 50 and 100 ppm (Figure 6b).
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b) Zeta poten ials of GO, GO-PEG, EGO and EGO-PEG dispersant were measu d at three different
concentrations (10, 50 and 100 ppm).
s indicated in Figure 6b, all standard alone graphene oxide derivatives had negatively-charged
particle surfaces bet een −25.8 to −41.9 mV. Interestingly, both and -PE sho ed increased
hydrodynamic stabilities as their negative zeta values were larger at higher concentrations (i.e., 41.9 mV at
100 ppm). Good particle stability is expected to increase the exposure time during physical interactions
between nanoparticles and microorganis s, which may enhance antifungal effect. In contrast, both
EGO and EGO-PEG particles showed be less stable in their aqueous states as their concentrations
increased, this can be seen from the small negative zeta values obtained at 100 ppm (25.8 and 35.4 mV).
As expected, the particle sizes of these graphene oxide derivatives are fairly polydispersed,
especially in their aqueous suspension forms. Nanoparticle tracking analyses were performed to
investigate the hydrodynamic behaviour of the four standard alone GO, GO-PEG, EGO and EGO-PEG
using dynamic light scattering (DLS) technique. The particle concentrations and distributions were
measured by capturing individual nanoparticles at real-time. Figure 7 shows the particle concentrations,
sizes and distributions in each graphene oxide sample. Of the samples, GO-PEG was found to have the
most uniform hydrodynamic size range between 75–375 nm when compared to other three samples.
In contrast, EGO-PEG appeared to have the most polydispersed property of all, where its hydrodynamic
size range distributed across 125–425 nm and beyond.
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3.3. Antimicrobial Activities of GO, GO-PEG, EGO and EGO-PEG against C. Albicans
Initial antifungal activities of nanomaterial standard dispersants (0.1% w/v), copper nanoparticles
(CuNPs), zinc oxide nanoparticles (ZnONPs) and the four graphene oxide derivatives (GO, GO-PEG,
EGO and EGO-PEG) were tested against C. albicans using ‘cut-well’ method [37]. The ‘cut well’ method
was repeated twice on separate agar plates and the antifungal activities of each nanomaterials were
observed in triplicates. This method provided fast antifungal screening results from testing a large
nu ber of nanomaterial samples, it also allowed the semi-quantification of the growth or reduction
of cell densities after nanoparticle exposures. In this study, ZnO was chosen as a negative control,
as zinc is known to be a growth nutrient for yeast cells [44,45]. As expected, C. albicans counts
(cfu/mL) increased to 1.0 × 108 after exposure to ZnONPs (Figure 8a). In this preliminary antifungal
study, standard alone CuNPs showed to be more efficacious against C. albicans when compared to
all other graphene oxide derivatives, as the resulting cell density was low, and the inhibitory effect
was clearly visualised through the haemocytometer (Figure 8d) when comparing with the control
culture (Figure 8b,c). The lack of viable cells after CuNPs treatment had caused great difficulty when
attempted to stain viable cells for further morphological studies using an optical microscope. After
a few attempts, it was possible to locate affected yeast cells after treatment with CuNPs using SEM,
the micrograph for which is shown in Figure 8e. As can be seen in Figure 8e, the yeast cell appeared
to have undergone the initial state of apoptosis, where pores were formed on the surface of the cell.
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It was unfortunate that the different stages of apoptosis could not be captured, as further microscopic
studies suggested that the anti-fungal effect observed in CuNPs occurred within 15–20 min.Nanomaterials 2020, 10, x FOR PEER REVIEW 13 of 19 
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Figure 8. (a) Antifungal susceptibility test of different nanomaterials. Haemocytometer images of
C. albicans control at (b) 10× magnification; (c) 60× magnification and (d) debris after treatment with
CuNPs. (e) SEM image of affected C. albicans cells after exposure to CuNPs.
With regards to the four graphene oxide derivatives, GO-PEG showed to be the best anti-fungal
agent of all (Figure 8a). A mean cell counts of 3.7 × 106 cfu/mL was measured; this was equivalent
to approximately a three tim s reduction when compared to the c ntrol count (6.6 × 107 cfu/mL).
The reduction effect exhi ited by the GO-PEG treatment was also observed in our later MIC study.
As the anti-fungal effects observed from th different graphene oxi es and their PEGylated derivativ s
were much slower than those of CuNPs. It was possible to capture the m rphologic l changes of
th affect d yeast cells after 16 h of treatments. Figure 9 shows SEM images (at 5 µm and 10 µm
magnifications) of the control C. albicans along with treated cells that were exposed to GO, GO-PEG,
EGO and EGO-PEG, respectively.
In general, a l C. albicans cultures that had been treated ith graphene oxides underwent
morphological changes. As shown in Figure 9 (top images), healthy yeast cells were grown which
appeared in spherical shapes with diameters betw en 3–4 µm, and the bud to hyphae transition
(fila ent) as observed in healthy ce ls as we l as a l treated ce ls. After treatment with GO, although
the overa l yeast structure maintained, the spores had clearly shrunk and changed from spherical to
oval shapes. In comparison, the morphological changes in yeast spores for the GO-PEG treated cells,
was more apparent, as clear debris remained from dead spores and hyphae which were sti l a tached
to the main branches. It is also worth noting that un-washed GO-PEG nano-sh ets were also present
and appeared to have tightly adhered to the yeast spores.
In comparison, after treatment with EGO, both yeast spores and hyphae suffered from heavy
morphological deformation. While the filament structure was still present, the spores were mostly
destroyed by the presence of EGO nano-sheets, which again can be seen in the SEM images (Figure 9).
The exposure of EGO-PEG over the yeast cells did not seem to have caused as much damage as the
corresponding precursor EGO, as SEM images showed both hyphae and spores, which although
deformed, where still present.
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3.4. Determination of a Synergistic Effect of GO, EGO and Their PEGylated Derivatives in the Presence of CuNPs
As mentioned in the previous section, the initial cell count studies using the cut-well method
provided an insight of the antifungal effect of different nanomaterials. However, it was difficult to
justify the accuracy of each count, as dead cells often appeared as debris and still stained following
treatment with Trypan Blue. Therefore, it was impossible to unambiguously identify viable yeast
cells appropriately using the haemocytometer. In order to quantify viable yeast cells and to evaluate
the synergistic antifungal effects of these graphene oxide derivatives, MIC assays were performed by
adding different ratios of copper nanoparticles (CuNPs) to GO, GO-PEG, EGO or EGO-PEG (Figure 10
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and Table 1). The viability curves (Figure 10) were obtained from reading the absorbance at λ 490 nm
produced by viable cells after quenching its reaction with the nanomaterials combinations using
XTT. Clear trends of reductions can be seen as concentrations of nanoparticles increased from all
16 experiments (Figure 10a–d).
Figure 10a–d show the viability curves of C. albicans after treatments of different GO:CuNPs
combinations using broth dilution method (500, 250, 125, 62, 31, 15 and 7 µm/mL). Four different
GO:CuNPs ratio combinations included 96:4, 70:30, 30:70 and 1:99 respectively were chosen in this
study. Instead of testing the standard alone GO derivatives and the CuNPs, we decided to manipulate
the respective GO:CuNPs ratios to 96:4 (
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when compared to its precursor GO (Figure 10a,b). This can also be seen in Table 1, at concentrations
500 µm/mL, the Candida viability decreased from 86% to 38% after exposure to GO and GO-PEG with
the minimal added CuNPs. Similarly, at concentrations 250 µm/mL, Candida viabilities also decreased
from 91% to 54% respective to the exposures with GO/GOPEG with 4% of CuNPs. This results also
agreed with the initial antifungal screening using the agar ‘cut-well’ method (Figure 8a), where lower
cell density was encountered in the GO-PEG standard alone treatment. The observed antifungal
ability in GO-PEG may be explained by the high colloidal values obtained from the zeta potential
measurements (−41.9 mV) and the mono-dispersive behaviour observed in the NTA study (Figure 7).
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adding different ratios of copper nanoparticles (CuNPs) to GO, GO-PEG, EGO or EGO-PEG (Figure 
10 and Table 1). The viability curves (Figure 10) were obtained from reading the absorbance at λ 490 
nm produced by viable cells after quenching its reaction with the nanomaterials combinations using 
XTT. Clear trends of reductions can be seen as concentrations of nanoparticles increased from all 16 
experi ents (Figure 10a–d). 
 
Figure 10. C. albicans viability assays obtained from combinations of (a) GO:CuNPs, (b) GO-
PEG:CuNPs, (c) EGO:CuNPs and (d) EGO-PEG:CuNPs. Four GO:CuNPs ratios were studied, 
including 96:4, 30:70, 70:30 and 1:99. 
Figure 10a–d show the viability curves of C. albicans after treatments of different GO:CuNPs 
combinations using broth dilution method (500, 250, 125, 62, 31, 15 and 7 μm/mL). Four different 
GO:CuNPs ratio combinations included 96:4, 70:30, 30:70 and 1:99 respectively were chosen in this 
study. Instead of testing the standard alone GO derivatives and the CuNPs, we decided to manipulate 
the respective GO:CuNPs ratios to 96:4 ( ) and 1:99 ( ), in hope to see any obvious synergistic 
indication. In the presence of 4% CuNPs, GO-PEG showed to exhibit much better antifungal activities 
Figure 10. C. albicans viability assays obtained from combinations of (a) GO:CuNPs, (b) GO-PEG:CuNPs,
(c) EGO:CuNPs and (d) EGO- EG:CuNPs. Four GO: s ratios were studied, including 96:4, 30:70,
70:30 an 1:9 .
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Table 1. C. albicans viability values obtained from IC 500 and 250 µg/mL of GO/EGO and PEGylated
GO/EGO in different ratio of copper nanoparticles (CuNPs).
Ratio of Different Graphene Oxide Derivatives to Copper Nanoparticles *
96:4 70:30 30:70 1:99
Inhibitory
Concentrations (µg/mL) 250 500 250 500 250 500 250 500
GO 90.6 86.0 73.8 58.8 31.6 28.5 69.5 38.1
GO-PEG 54.3 38.4 74.6 28.6 43.9 23.6 61.7 32.5
EGO 66.2 52.2 77.4 36.4 67.9 29.2 56.1 29.5
EGO-PEG 67.4 58.8 84.3 39.8 66.6 24.6 51.7 15.3
* 96:4 represents a combination of 96% of GO based material with 4% CuNPs; 70:30 represents a combination of
70% of GO based material with 30% CuNPs; 30:70 represent a combination of 30% of GO based material with 70%
CuNPs; 1:99 represents a combination of 1% of GO based material with 99% CuNPs.
The best MIC50 values were found when 30:70 combinations were employed in both GO:CuNPs
(185 µm/mL) and GOPEG:CuNPs (225 µm/mL). Although the 30:70 GO:CuNPs combination
appeared to have lower inhibitory concentration for deactivating half (MIC50) of the yeast colonies,
the corresponding GOPEG:CuNPs appeared to have the deactivations more directly proportional to
the nanoparticle concentrations. Thus resulting a slightly lower viability values at higher concentration
(Table 1), for instance, 24% of yeast viability was encountered in the 30:70 EGO:CuNP combination at
500 µm/mL (ca. 29% for corresponding GO:CuNPs combination).
Although the yeast viability results shown in Figure 10c,d illustrated all antifungal activities
were directly proportional to the increasing concentrations of the EGO and EGO-PEG in CuNPs
combinations, the synergistic effects were not as encouraged as those observed in GO and GO-PEG.
The best MIC50 values of 320 µm/mL and 265 µm/mL were measured only when very high ratio of
CuNPs were employed in EGO:CuNPs and EGOPEG:CuNPs (Figure 10c,d). Nevertheless, the lowest
viability value (15%) was indeed found when 99% of CuNPs was employed in EGO-PEG at the
inhibitory concentration of 500 µg/mL (Table 1). This viability value was significantly lower than those
were found in GO, GO-PEG and EGO (38%, 33% and 30%) with the same CuNPs ratio.
4. Conclusions
Coupling of PEG to the graphene-based nanomaterials, GO and EGO, via amide bond syntheses
were achieved, these had subsequently yielded the two PEGylated products, GO-PEG and EGO-PEG
(Figure 1). FTIR spectra of the resulting GO-PEG and EGO-PEG (Figure 2) confirmed the newly formed
amide bonds (1732 and 1712 cm−1 NH-CO IR stretches) in both PEGylated products. Raman spectra of
both PEGylated products GO-PEG and EGO-PEG (Figure 3b,d) confirmed that their carbonaceous
structures remained unchanged after isolations from the coupling syntheses. Whilst SEM images
showed the changes in the layered-structures in both PEGyalted GO and EGO, the corresponding
TEM identified the directional and morphological changes of the lattice structures in both GO-PEG
and EGO-PEG from their starting materials (Figures 4 and 5). In addition, the changes in pH from the
starting GO/EGO (pH 2.6–3.3) to give the neutralised GO-PEG and EGO-PEG products (pH 6.7–6.9)
had further supported that the PEGylated had occurred (Figure 6a).
To assess the antifungal abilities and synergistic potentials of these graphene oxide derivatives,
susceptibility tests of C. albicans were performed using the in vitro cut well method in the presence of
different nanoparticle dispersants (0.1 w/v%). Among all the nanomaterials that were investigated
(Figure 8a), CuNPs showed to be the most effective antifungal reagent against C. albicans, and the
strength of antifungal efficacy was followed by GO-PEG > EGO-PEG > GO > EGO. These findings
were in line with the MIC results that are shown in Figure 10. The viability results indicated that
GO-PEG (Figure 10b) appeared to be as good antifungal agent as CuNPs, this can be explained by the
high colloidal stability displayed in the corresponding zeta potential (−41 mV). The antifungal effect
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observed in GO-PEG was also supported by the SEM images (Figure 9), where physical interactions
between GO-PEG and C. albicans had caused heavy damages and deformations of the spores and
hyphae structures. It was also interesting to see the different morphological changes in C. albicans after
treatments with different GO derivatives (Figure 9) and CuNPs (Figure 8e).
MIC studies suggested that the combination of graphene oxides and CuNPs at a ratio of 30:70
provided the optimal synergistic effects in the case of GO:CuNPs (Figure 10a) and GO-PEG:CuNPs
(Figure 10b) where their MIC50 values were found to be between 185–225 µg/mL.
In summary, GO-PEG, GO:Cu (30:70), GO-PEG:Cu (30:70) and EGOPEG:CuNPs (1:99) showed
to have good potential to be used as antifungal reagents against Candida albicans. From this study,
we found that antifungal activities can be enhanced by manipulating the ratio of graphene oxide
derivatives and CuNPs. This study supports the engineering of non-ingestible nanoparticles as
potential components to be embedded or incorporated into biomedical dressings, instrument and/or
other medical devices to combat fungal infections in the future.
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